Moon AM, Singal AG, Tapper EB. Contemporary Epidemiology of Chronic Liver Disease and Cirrhosis. Clin Gastroenterol Hepatol. 2020;18:2650–2666.

Article  PubMed  Google Scholar 

Rahib L, Wehner MR, Matrisian LM, Nead KT. Estimated Projection of US Cancer Incidence and Death to 2040. JAMA Netw Open. 2021;4:e214708.

Article  PubMed  PubMed Central  Google Scholar 

Singal AG, Zhang E, Narasimman M et al. HCC surveillance improves early detection, curative treatment receipt, and survival in patients with cirrhosis: A meta-analysis. J Hepatol. 2022;77:128–139.

Article  PubMed  PubMed Central  Google Scholar 

Singal AG, Llovet JM, Yarchoan M et al. AASLD practice guidance on prevention, diagnosis, and treatment of hepatocellular carcinoma. Hepatology. 2023.

Wolf E, Rich NE, Marrero JA, Parikh ND, Singal AG. Use of Hepatocellular Carcinoma Surveillance in Patients With Cirrhosis: A Systematic Review and Meta-Analysis. Hepatology. 2021;73:713–725.

Article  PubMed  Google Scholar 

Singal AG, Yopp AC, Gupta S et al. Failure rates in the hepatocellular carcinoma surveillance process. Cancer Prev Res (Phila). 2012;5:1124–1130.

Article  PubMed  PubMed Central  Google Scholar 

Parikh ND, Tayob N, Al-Jarrah T et al. Barriers to Surveillance for Hepatocellular Carcinoma in a Multicenter Cohort. JAMA Netw Open. 2022;5:e2223504.

Article  PubMed  PubMed Central  Google Scholar 

Liu TL, Barritt AST, Weinberger M, Paul JE, Fried B, Trogdon JG. Correction: Who Treats Patients with Diabetes and Compensated Cirrhosis. PLoS One. 2018;13:e0190756.

Article  PubMed  PubMed Central  Google Scholar 

McGowan CE, Edwards TP, Luong MU, Hayashi PH. Suboptimal surveillance for and knowledge of hepatocellular carcinoma among primary care providers. Clin Gastroenterol Hepatol. 2015;13:799–804.

Article  PubMed  Google Scholar 

Radley A, Robinson E, Aspinall EJ, Angus K, Tan L, Dillon JF. A systematic review and meta-analysis of community and primary-care-based hepatitis C testing and treatment services that employ direct acting antiviral drug treatments. BMC Health Serv Res. 2019;19:765.

Article  PubMed  PubMed Central  Google Scholar 

Ioannou GN, Beste LA, Green PK et al. Increased Risk for Hepatocellular Carcinoma Persists Up to 10 Years After HCV Eradication in Patients With Baseline Cirrhosis or High FIB-4 Scores. Gastroenterology. 2019;157:e1264.

Article  Google Scholar 

Kim NJ, Vutien P, Berry K, Ioannou GN. Hepatocellular Carcinoma Risk Declines but Remains High Enough for Screening in the First 7 Years After Hepatitis C Virus Cure With Direct-Acting Antivirals in Patients With Cirrhosis or High Fibrosis-4 Score. Gastroenterology. 2022;163:e1103.

Article  Google Scholar 

Kim NJ, Vutien P, Cleveland E, Cravero A, Ioannou GN. Fibrosis Stage-specific Incidence of Hepatocellular Cancer After Hepatitis C Cure With Direct-acting Antivirals: A Systematic Review and Meta-analysis. Clin Gastroenterol Hepatol. 2023;21:e1725.

Article  Google Scholar 

Ioannou GN, Green PK, Beste LA, Mun EJ, Kerr KF, Berry K. Development of models estimating the risk of hepatocellular carcinoma after antiviral treatment for hepatitis C. J Hepatol. 2018;69:1088–1098.

Article  PubMed  PubMed Central  Google Scholar 

Ioannou GN, Tang W, Beste LA et al. Assessment of a Deep Learning Model to Predict Hepatocellular Carcinoma in Patients With Hepatitis C Cirrhosis. JAMA Netw Open. 2020;3:e2015626.

Article  PubMed  PubMed Central  Google Scholar 

Ganne-Carrie N, Layese R, Bourcier V et al. Nomogram for individualized prediction of hepatocellular carcinoma occurrence in hepatitis C virus cirrhosis (ANRS CO12 CirVir). Hepatology. 2016;64:1136–1147.

Article  CAS  PubMed  Google Scholar 

Degasperi E, Galmozzi E, Pelusi S et al. Hepatic Fat-Genetic Risk Score Predicts Hepatocellular Carcinoma in Patients With Cirrhotic HCV Treated With DAAs. Hepatology. 2020;72:1912–1923.

Article  CAS  PubMed  Google Scholar 

Innes H, Jepsen P, McDonald S et al. Performance of models to predict hepatocellular carcinoma risk among UK patients with cirrhosis and cured HCV infection. JHEP Rep. 2021;3:100384.

Article  PubMed  PubMed Central  Google Scholar 

Innes H, Hamill V, McDonald S et al. Comparing predicted probability of hepatocellular carcinoma in cirrhosis patients to the general population: an opportunity to improve risk communication? Am J Gastroenterol. 2022.

Moon AM, Ioannou GN. Moving Away From a One-Size-Fits-All Approach to Hepatocellular Carcinoma Surveillance. Am J Gastroenterol. 2022;117:1409–1411.

Article  PubMed  Google Scholar 

Serper M, Tapper EB, Kaplan DE, Taddei TH, Mahmud N. Patterns of Care Utilization and Hepatocellular Carcinoma Surveillance: Tracking Care Across the Pandemic. Am J Gastroenterol. 2023;118:294–303.

Article  CAS  PubMed  Google Scholar 

Beste LA, Ioannou GN, Yang Y, Chang MF, Ross D, Dominitz JA. Improved surveillance for hepatocellular carcinoma with a primary care-oriented clinical reminder. Clin Gastroenterol Hepatol. 2015;13:172–179.

Article  PubMed  Google Scholar 

Dillman DA. Mail and Internet Surveys: The Tailored Design Method. New York: Wiley; 2000.

Google Scholar 

Dillman DA, Clark JR, Sinclair MD. How Prenotice Letters, Stamped Return Envelopes and Reminder Postcards Affect Mailback Response Rates for Census Questionnaires. Survey Methodology. 1995;21:159–165.

Google Scholar 

Henderson LM, Benefield TS, Bearden SC et al. Changes in Physician Knowledge, Attitudes, Beliefs, and Practices regarding Lung Cancer Screening. Ann Am Thorac Soc. 2019;16:1065–1069.

Article  PubMed  PubMed Central  Google Scholar 

Henderson LM, Jones LM, Marsh MW, Benefield T, Rivera MP, Molina PL. Lung Cancer Screening Practices in North Carolina CT Facilities. J Am Coll Radiol. 2017;14:166–170.

Article  PubMed  Google Scholar 

Henderson LM, Jones LM, Marsh MW et al. Opinions, practice patterns, and perceived barriers to lung cancer screening among attending and resident primary care physicians. Risk Manag Healthc Policy. 2017;10:189–195.

Article  PubMed  Google Scholar 

Henderson LM, Marsh MW, Benefield T et al. Characterizing the Mammography Technologist Workforce in North Carolina. J Am Coll Radiol. 2015;12:1419–1426.

Article  PubMed  PubMed Central  Google Scholar 

Groves RM, Peytcheva E. The Impact of Nonresponse Rates on Nonresponse Bias: A Meta-Analysis. Public Opinion Quarterly. 2008;72:167–189.

Article  Google Scholar 

Kalton G. Introduction to Survey Sampling. University Paper Series on Quantitative Applications in the Social Sciences, City; Sage Publications;1983.

European Association for the Study of the Liver. EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma. J Hepatol. 2018;69:182–236.

Article  Google Scholar 

Dalton-Fitzgerald E, Tiro J, Kandunoori P, Halm EA, Yopp A, Singal AG. Practice patterns and attitudes of primary care providers and barriers to surveillance of hepatocellular carcinoma in patients with cirrhosis. Clin Gastroenterol Hepatol. 2015;13:e791.

Article  Google Scholar 

Khalili M, Guy J, Yu A et al. Hepatitis B and hepatocellular carcinoma screening among Asian Americans: survey of safety net healthcare providers. Dig Dis Sci. 2011;56:1516–1523.

Article  PubMed  Google Scholar 

Kim NJ, Rozenberg-Ben-Dror K, Jacob DA et al. Provider Attitudes Toward Risk-Based Hepatocellular Carcinoma Surveillance in Patients With Cirrhosis in the United States. Clin Gastroenterol Hepatol. 2022;20:183–193.

Article  PubMed  Google Scholar 

Schillie S, Wester C, Osborne M, Wesolowski L, Ryerson AB. CDC Recommendations for Hepatitis C Screening Among Adults - United States, 2020. MMWR Recomm Rep. 2020;69:1–17.

Article  PubMed  PubMed Central  Google Scholar 

Archer AJ, Belfield KJ, Orr JG, Gordon FH, Abeysekera KW. EASL clinical practice guidelines: non-invasive liver tests for evaluation of liver disease severity and prognosis. Frontline Gastroenterol. 2022;13:436–439.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Surveillance for hepatocellular carcinoma in adults, 2023. https://www.uptodate.com/contents/surveillance-for-hepatocellular-carcinoma-in-adults#H1621039315. Accessed September 19, 2023.

Marrero JA, Kulik LM, Sirlin CB et al. Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases. Hepatology. 2018;68:723–750.

Article  PubMed  Google Scholar 

Hsu CD, Henderson LM, Jackson BE et al. Hepatocellular Carcinoma Surveillance among Individuals with Cirrhosis: Trends by Payer, Etiology, and Calendar Year, from a Statewide, Multi-Payer Dataset, 2010–2018. Cancer Epidemiol Biomarkers Prev. 2023:OF1-OF10.

Rogal SS, Yakovchenko V, Gonzalez R et al. The Hepatic Innovation Team Collaborative: A Successful Population-Based Approach to Hepatocellular Carcinoma Surveillance. Cancers (Basel). 2021;13:2251.

Article  PubMed  PubMed Central  Google Scholar 

Bloomberg. Survey Response Rates Are Down Since Covid. That's Worrying for US Economic Data, 2023. https://www.bloomberg.com/news/articles/2023-02-15/us-economic-data-threatened-by-survey-non-responses?sref=qfHtwehS#xj4y7vzkg. 2023.